Providing early diagnosis and patient-centered treatment for neurotrophic keratitis (NK)—a condition that results from disrupted corneal innervation—can pose challenges. Management of NK requires the identification of symptoms that may be subtle and an understanding of the factors underlying each patient’s...

Review of data presented at recent conferences on newer therapies for neovascular age-related macular degeneration and diabetic macular edema. This online activity is designed to update clinicians on data presented at meetings of retina specialists; these include the Retina World...

This online, on-demand virtual symposium brings together renowned experts on Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available therapies. This educational activity is an archive of the...

This online activity is designed to update clinicians on data presented at the 25th EURETINA Congress that was held from September 4 to 7, 2025, in Paris, France; the 59th Annual Meeting of the Retina Society that was held on...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

The BURST CME™ format is an online, on-demand video program designed to deliver concise, modular education. In these modules, Uday Devgan, MD, FACS, FRCS, reviews presbyopia-correcting intraocular lenses (IOLs) and toric IOLs for patients with astigmatism. Topics discussed include the...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

This video-based program is designed for eye care professionals to explore the diagnosis and potential treatment of patients with X-linked retinitis pigmentosa (XLRP) through a unique perspective, putting the patient’s voice front and center. A patient will lend his expertise...

Although anti-VEGF therapies have advanced the management of nAMD and DME, limitations with their use – including the need for frequent injections – led to the development of newer anti-VEGF agents. In this program, a panel of expert faculty share...